I am who I say I am
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Like I said they need an IB who knows what they are doing and has the resources to make it happen.
I was around for that r/s. There wasn't enough retail interest to have raised much money. It took me forever to sell my shares.
They need to make a connection with an investment company like Paulson who knows financing and has investors.
" i conclude this company is definitely investor unfriendly.imo"
That's for sure and for as long as I can remember.
I'd like to know why she thinks things will be different this time vs previous reverse splits.
Thanks Shannon and Marc! Could not be a worse duo as far as creatinf shareholder value.
Great. Try and order something and see what happens. I could not get my order to process late last week.
I sent a note of inquiry about my difficulty ordering via the contact page and have not gotten a response.
Maybe an announcement will come next week.
I have some money in my pocket. A few bills and some loose change.It isn't a lot but considering the current value is .000001 it would seem like a fortune.
To: The Holders of the Common Stock of Pacific Ventures Group, Inc.
Re: Action by Written Consent in Lieu of a Special Meeting of Shareholders
This Information Statement is furnished by the Board of Directors of Pacific Ventures Group, Inc., a Delaware corporation (the “Company”), to holders of record of the Company’s common stock, $0.001 par value per share (the “Common Stock”), at the close of business on June 27, 2023. The purpose of this Information Statement is to inform the Company’s shareholders of an action taken by the written consent of the holders of a majority of the Company’s voting stock, dated as of June 27, 2023, in lieu of a special meeting of shareholders, to wit:
The authorization and approval of a reverse split of the issued and outstanding shares of the Company’s Common Stock, including shares of Common Stock reserved for issuance, in a ratio to be determined by the Company’s Board of Directors, not to exceed a one-for-two-hundred-fifty (1:250) basis (the “Reverse Split”).
The foregoing actions were approved on June 27, 2023, by the Company’s Board of Directors. In addition, on June 27, 2023, the holder of 90.28% of the voting power of the Company’s outstanding voting securities (the “Consenting Stockholder”), as of the record date, approved the foregoing action. The number of shares voting for the Reverse Split was sufficient for approval.
Section 228 of Title 8 of the Delaware General Corporation Law provides, in part, that any action required or permitted to be taken at a meeting of the stockholders may be taken without a meeting if, before or after the action, a written consent thereto is signed by stockholders holding at least a majority of the voting power, except that if a different proportion of voting power is required for such an action at a meeting, then that proportion of written consents is required.
In order to eliminate the costs and management time involved in obtaining proxies and, in order to effect the above action as early as possible in order to accomplish the purposes of the Company as herein described, the Board of Directors consented to the utilization of, and did in fact obtain, the written consent of the Consenting Stockholder who owns shares representing a majority of the Company’s voting stock.
The entire cost of furnishing this Information Statement will be borne by the Company. The Company may request brokerage houses, nominees, custodians, fiduciaries and other like parties to forward this Information Statement to the beneficial owners of the Company’s Common Stock held of record by them and will reimburse such persons for their reasonable charges and expenses in connection therewith.
WE ARE NOT ASKING YOU FOR A PROXY,
AND YOU ARE REQUESTED NOT TO SEND US A PROXY.
No action is required by you. The accompanying Information Statement is furnished only to inform the Company’s shareholders of the action described above before it takes place, in accordance with Rule 14c-2 of the Securities Exchange Act of 1934. This Information Statement will be first distributed to you on or about July 19, 2023.
By Order of the Board of Directors
/s/ Shannon Masjedi
Shannon Masjedi
Chief Executive Officer and Director
[ * ], 2023
Los Angeles, California
I don't know if considering the companies current status if a SEC filing would need to be done or not.
Good to know but...I'd like to know about the acquisition and public order website...preferably no later than the end of the first week of July.
100% in agreement she should have a hefty raise. I mean who has performed better than Shannon for shareholders? She is way in front of everyone including the Oracle of Omaha.
I agree volume was low but cosidering the illegal naked shorting aspect, official volume may not reflect reality.
I did email the SEC. If they respond, I'll let the board know. So far no response from CR.
I sent the SEC PR about Sabby to CR. Folks might want to reach out to the SEC and inquire if CRXM was one of Sabbys targets.
I suspect some improvement has been made with the debt. Hopefully new revenue is coming in as well. My patience is pretty much gone though. News of accomplishments would be appreciated.
AARP and Omaha Steaks having $150 giftcard sweepstake. Meanwhile, PACV can't be bothered to do shit with their previously announced online order platform. The most respected woman in meat must be hanging with her buddy Martha over at the SI photo shoot.
As of 10:00 am EST no one is willing to pay .0008 for shares of PACV. Thanks for the great communication management.
Please keep posts related to PACV as per the rules.
What the fact that there is someone alive at HQ shouldn't be considered a huge positive for shareholders? We should be more grateful.
How does this filing help the common shareholder?
2/3's of the way through the second quarter and we got nothing
PayPal sent me an email 50% off Omaha Steaks.
Be nice to have a website I could order from PACV instead.
Sure hope their is a deal brewing that will be made public soon soaking all of management's and the accounting firms time.
Common shareholders are not on a need to know basis about noteholders or anything else for that matter.
Past time. I wonder what the hold up is. How long have we been hearing about the acquisition and new website?
Someone needs to pony up for a subscription. I mean geez, the guy is offering to possibly buy a ton of shares.
Try these:
creinhard@genebiotherapeutics.com
info@genebiotherapeutics.com
I used them recently. Did not kick back. No response though. I think I relayed to him that angionetics address wasn't working.
"I am still hopeful here but refuse to believe anything until I see it in official form."
Could not agree more. I think CR needs to put some type of update out. I just don't see why a legit CEO would leave investors hanging this long. A pending partnership/uplisting or buyout would be the exception.
What emails addresses are you using?
Given Altitrade Partners deep research I hope they/you are right. My personal preference, as well as my families, would be to see progress being made and a private buyout. This would be so much less complicated for everyone.
I wonder if Altitrade Partners has done a valuation recently. It has been a while. Has the market for Generx changed? Any other therapies catching up?
I'd also like to understand what the situation with Nostrum is at this time. Why did they take such a large interest in CRXM only to have Generx sit on a shelf?
Heck of a way to lower your cost average in case we open back up on a higher exchange based on momentum from partnerships and trial progress. Better yet a buyout.
Strong conviction there Altitrade Partners.
I recall you laying that out for folks in your blogs etc. I don't disagree it may turn out to be a benefit.
Still, CRXM is a public company with shareholders who purchased shares on the open market based on public documents etc.
It wouldn't hurt for CRXM to put out an update, even if it is just as a banner on the website for those of us following along. I too trust CR to move things along. Considering the silence, lack of filings and reported difficulty reaching CR, it would be a help to hear something.
Green light red light green light red light green light red light....you get the idea
From IR today:
Kevin Holmes (kevinholmes@chesapeakegp.com)
To:you Details
Dr. xxxxxxxxx,
The company is working diligently to complete both the 10K and 10Q filing to become current. It is anticipated both will be filed shortly.
Kevin Holmes
Chesapeake Group
410-825-3930
As I recall he is in at a very good average price. I doubt he is very concerned about his investment. I could be wrong. No one likes losing money. Especially considering the company clearly lead investors to believe they were getting current etc.